Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!

Ticker
ALIKO.PA

Price
1.41
Stock movement down
-0.04 (-2.76%)
Company name
Ikonisys SA
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Medical Devices
Markkapitalisasie
15.88M
Ondernemingswaarde
-
Prys/Verkope
21.28
Prys/Boek
-
Dividendopbrengs
-
Dividendgroei
-
Groei jare
-
FCF uitbetaling
-
Agterlopende P/E
-
Volgende P/E
-
PEG
-
EPS groei
-
1 jaar opbrengs
-14.55%
3 jaar opbrengs
-21.00%
5 jaar opbrengs
-
10 jaar opbrengs
-
Laaste opgedateer: 2024-12-25

DIVIDENDE

ALIKO.PA betaal nie dividende nie of geen data is ontvang nie

WAARDERING

Waarderingsverhoudings

Loading...
Waarderingsverhoudings gegewens
Agterlopende P/E-
Prys tot OCF-
Prys tot FCF-
Prys tot EBITDA-
EV tot EBITDA-

Waardering (Verkope/Boekwaarde)

Loading...
Waardering (Verkope/Boekwaarde) gegewens
Prys tot verkope21.28
Prys tot Boekwaarde-
EV tot verkope-

FINANSIËLE

Per aandeel

Loading...
Per aandeel gegewens
Huidige aandeeltelling11.26M
EPS (TTM)-0.35
FCF per aandeel (TTM)-0.14

Inkomstestaat

Loading...
Inkomstestaat gegewens
Inkomste (TTM)746.10K
Bruto wins (TTM)-195.29K
Bedryfsinkomste (TTM)-3.72M
Netto inkomste (TTM)-3.67M
EPS (TTM)-0.35
EPS (1j vorentoe)-0.04

Marges

Loading...
Marges gegewens
Bruto marge (TTM)-26.17%
Bedryfsmarge (TTM)-499.14%
Winsgrens (TTM)-491.69%

Balansstaat

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Balansstaat gegewens
Kontant0.00
Netto debiteure0.00
Totale bedryfsbates0.00
Klandisiewaarde0.00
Ontasbare bates0.00
Eiendom, aanleg en toerusting0.00
Totale bates0.00
Rekeninge betaalbaar0.00
Kort/huidige langtermynskuld0.00
Totale bedryfslaste0.00
Totale laste0.00
Aandeelhouersbelang0.00
Netto tasbare bates0.00

Kontantvloei

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Kontantvloei gegewens
Bedryfskontantvloei (TTM)-914.22K
Kapitale uitgawes (TTM)542.44K
Vrye kontantvloei (TTM)-1.46M
Dividende betaal (TTM)0.00

Finansiële opbrengste

Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Finansiële opbrengste gegewens
Opbrengs op ekwiteit-
Opbrengs op bates-
Opbrengs op belegde kapitaal-
Kontant opbrengs op belegde kapitaal-

AANDELE INLIGTING

Aandele grafiek

Loading...
Aandele prys data
Open1.45
Daaglikse hoog1.45
Daaglikse laag1.36
Daaglikse volume3K
Hoogtepunt van alle tye4.59
1j analiseraaming4.10
Beta0.70
EPS (TTM)-0.35
Dividend per aandeel-
Ex-dividend datum-
Volgende verdienste datum-

Afwaartse potensiaal

Loading...
Afwaartse potensiaal gegewens
ALIKO.PAS&P500
Huidige prysdaling vanaf die hoogste punt van alle tye-69.28%-1.07%
Hoogste prysdaling-74.95%-56.47%
Datum van hoogste daling26 Oct 20239 Mar 2009
Gemiddelde daling vanaf hoogtepunt-57.60%-11.13%
Gemiddelde tyd tot nuwe hoogtepunt295 days12 days
Maksimum tyd tot nuwe hoogtepunt882 days1805 days
MAATSKAPPY BESONDERHEDE
ALIKO.PA (Ikonisys SA) company logo
Markkapitalisasie
15.88M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of gene rearrangements commonly associated with non-small cell lung carcinoma; oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene, which is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. In addition, it offers liquid biopsy/CTC bladder cancer detection and breast cancer early diagnostics products; CYTOfast vial solution for any type of cellular analysis; CYTOfast kit urine, a three day cytological urine test solution; CYTOfast PLUS, a liquid-phase processor that prepares thin-layer cytological samples from liquid-phase specimen; and Ikonisys intelligent application, a software designed to automatically quantify, qualify, and present cells for review. Ikonisys S.A. was incorporated in 2021 and is headquartered in Paris, France.
Werknemers
10
Beleggerverhoudings
-
CEO
Land
France
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Geen gebeure gevind nie
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
PARIS, December 04, 2024--Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully a...
4 Desember 2024
PARIS, November 25, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution f...
25 November 2024
PARIS, November 19, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution ...
19 November 2024
PARIS, November 18, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution f...
18 November 2024
PARIS, November 12, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution f...
12 November 2024
PARIS, November 04, 2024--Regulatory News: Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for...
4 November 2024
PARIS, October 31, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution fo...
31 Oktober 2024
PARIS, October 10, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancer through fully automated solutions for medical...
10 Oktober 2024
PARIS, October 03, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution f...
3 Oktober 2024
PARIS, October 01, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution f...
1 Oktober 2024
Volgende bladsy